For better or for worse, bosses don’t spend much time thinking about your needs and worrying about helping you with your career advancement. Bosses, like most people at work, are busy people with their own jobs, their own lives, and their own concerns.
Ed. Note: This is cross-posted from the Bureau of Economic Analysis's blog. It highlights the coordination and collaboration between BEA and NOAA to bring value in data and services to the American public.How many jobs are created from the construction of a new bridge or an increase in tourism?
The Bureau of Economic Analysis’ (BEA) new Web portal on the ocean
and Great Lakes economy shows how the Bureau’s Regional Input-Output
Modeling System (RIMS II) can be used to provide answers to such
questions. The new Web site stems from a joint project with the Commerce
Department’s National Oceanic and Atmospheric Administration.
RIMS II, a regional economic model, is used by investors, planners,
and elected officials to objectively assess the returns to projects
ranging from a new sports stadium to a new bridge. The returns include
the short- and long-term increases in jobs and spending associated
with the projects.
The idea behind the results of RIMS II is that an initial change in
economic activity leads to additional changes in economic activity in
other parts of an economy—for example, building a new bridge leads to
increased production of concrete and steel. The increased production of
concrete and steel leads to more mining. Workers benefiting from these
increases may also enjoy bigger paychecks, so they may then spend more
by eating out at nicer restaurants or splurging more on entertainment.
Rite Aid Corporation (NYSE:RAD) has agreed today to buy a leading pharmacy benefit manager, Envision Pharmaceutical Services, in a cash-and-stock deal worth $2 billion. Also known as EnvisionRx, Envision Pharmaceutical Services is owned by the global private equity firm TPG Capital.
Shares of Rite Aid escalated 8.84% in pre-market trade today after the deal was announced, which could potentially enhance its competitive position in the rapidly changing pharmacy retail market.
Rite Aid Corporation (RAD) has retreated roughly 19% in the last three months, underperforming competitor Walgreen Company (WAG) by about nine percentage points (ppts); the company has continued to underperform Walgreen in terms of topline growth.